Description:
Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated.
- Molecular Weight: 157.10
- Molecular Formula: C5H4FN3O2
Purity: ≥97%
Canonical SMILES:
C1=C(N=C(C(=O)N1)C(=O)N)F
InChI:
InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)
InChIKey: ZCGNOVWYSGBHAU-UHFFFAOYSA-N
- Boiling Point: 552.6±50.0°C at 760 mmHg
- Melting Point: >151°C (dec.)
- Solubility: Soluble in Chloroform (Slightly, Sonicated), DMSO (Slightly), Methanol (Slightly, Sonicated)
- Appearance: White to Light Pink Solid
- Storage: Store at 2-8°C under inert atmosphere
Synonyms:
Favipiravir; Avigan; Abigan; Avifavir; Areplivir; T-705; Favipira; Favilavir; 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide; 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide; 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide
More details are to be found on supplier website
